| 2023 | Case 1 | F/55 | Tongue | None | MRI showed a vaguely-bordered soft tissue thickening at the anterior tongue. In addition, MRI showed an intermediate T1 signal and slightly high T2 signal lesion at the right side of the tongue, which was about 3.6 cm×1.3 cm. The lesion demonstrated heterogeneous contrast enhancement | Ⅰ EA | / |
| 2024 | Case 2 | M/44 | Hard palate | None | MRI illustrated a vaguely-bordered soft tissue thickening, which measured approximately 3.4 cm×2.7 cm×1.2 cm and showed a slightly low T1 signal and slightly high T2 signal. The lesion demonstrated heterogeneous contrast enhancement. There were several enlarged lymph nodes in the level Ⅱ‒level Ⅳ cervical | Ⅳ A | GemOx-D |
| 2014 | 1/[2] | M/59 | The right side of the tongue base | None | CT scan presented an ill-defined, heterogeneous enhancing soft tissue mass lesion in the right tongue base and enlarged lymph nodes in the right level Ⅱ | Ⅱ A | CHOP+RT+VMAT |
| 2016 | 2/[3] | F/50 | The left side of the anterior tongue | None | MRI T2WI showed a bordered lesion at the anterior tongue | Ⅰ | None |
| 2017 | 3/[4] | F/42 | Near the median sulcus of the tongue | None | Enhanced MRI showed a bordered, bar-shaped, irregular lesion with intermediate T1 signal and slightly high T2 signal in the right portion of the tongue, and its size was about 8.5 mm×24.5 mm | / | Surgery, CHOP |
| 2018 | 4/[5] | F/25 | Upper lip, palate, and maxillary sinus | Fever, weight loss | CT scan with contrast showed an expansive and infiltrative formation with irregular contours and ulceration, extending from the upper lip to the nasolabial sulcus, with infiltration into the epidermis and nasal mucosa. The formation affected the right tear duct without bone involvement. In addition, CT showed a bilateral increase in the number and size of the cervical lymph nodes, mainly the submandibular chain | Ⅳ B | CHOEP |
| 2020 | 5/[6] | M/ 75‒80 | The right side of the tongue base | None | CT scan showed a well-bordered cystic mass (2 cm in diameter) at the right base of the tongue extending into the pharynx | Ⅳ A | GDP+CHOP |
| 2021 | 6/[7] | F/63 | Submandibular region | / | / | / | / |
| 2021 | 7/[7] | M/67 | Buccal mucosa | / | / | / | / |
| 2021 | 8/[7] | M/57 | Hard palate | / | / | / | / |
| 2021 | 9/[7] | M/38 | Soft palate | / | / | / | / |
| 2021 | 10/[7] | M/59 | Buccal mucosa | / | / | / | / |
| 2021 | 11/[7] | F/56 | Tonsil | / | / | / | / |
| 2021 | 12/[7] | F/66 | Tonsil | / | / | / | / |
| 2023 | 13/[8] | M/34 | Right buccal mucosa | None | CT scan imaging showed destructive and expansive mass with central necrosis, extending to maxillary and ethmoid sinuses | Ⅱ EA | CHOEP+RT |
| 2024 | 14/[9] | F/37 | Maxillary gingiva | None | / | / | Anthracycline-based regimens |
| 2024 | 15/[9] | M/44 | Buccal mucosa | None | / | / | / |
| 2024 | 16/[9] | F/62 | Palate and gingiva | None | / | / | Anthracycline-based regimens |
| 2024 | 17/[9] | M/55 | Palate and maxillary sinus | None | CT scan illustrated the neoplasm invading the maxillary sinus and the orbital cavity, and extending toward the base of the skull | / | Anthracycline-based regimens |
| 2024 | 18/[9] | M/61 | Soft palate and tonsil | None | / | / | / |